Neurocrine Biosciences | Capitalización De Mercado



Market Capitalization Cambio Fecha
AbbVie USD 347.61B 23.02B 2025-05
Agios Pharmaceuticals USD 1.76B 109M 2025-05
ALKERMES USD 4.95B 295M 2025-05
Alnylam Pharmaceuticals USD 33.57B 1.55B 2025-05
Amgen USD 150.06B 10.09B 2025-05
Biogen USD 17.89B 4.39B 2025-05
BioMarin Pharmaceutical USD 11.72B 824M 2025-05
Cytokinetics USD 5.55B 661M 2024-12
Dynavax Technologies USD 1.68B 219M 2024-12
Gilead Sciences USD 129.47B 10.21B 2025-05
Halozyme Therapeutics USD 6.08B 1.17B 2024-12
Incyte USD 13.94B 2.22B 2025-05
Ionis Pharmaceuticals USD 4.78B 14M 2025-05
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Pfizer USD 137.09B 6.62B 2025-05
Prothena USD 745M 155M 2024-12
Regeneron Pharmaceuticals USD 66.6B 2.74B 2025-05
Repligen USD 7.85B 699M 2025-05
Sarepta Therapeutics USD 11.78B 128M 2024-12
Teva Pharmaceutical Industries ILS 91.91B 16.81B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Vertex Pharmaceuticals USD 103.45B 16.4B 2024-12



Neurocrine Biosciences Capitalización De Mercado - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.